Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
LiberaBio logo — Addressing "undruggable"​ oncology targets by delivering who...

LiberaBio

Addressing "undruggable"​ oncology targets by delivering whole antibodies inside the tumor and metastatic cells.

Founded 2018 Spain Spain 11 employees Grant Total: $1.30M Biopharma, Life Sciences +1

General Information

Company Name LiberaBio
Founded Year 2018
Location Spain Spain +2
Founders / Decision Makers
Team member
Employees 11
Industries Biopharma, Life Sciences, Pharmaceutical
Funding Stage Grant
Social

Get notified when LiberaBio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About LiberaBio

LiberaBio, a preclinical stage biotech company founded in 2018 and headquartered in Spain, focuses on developing new oncology treatments using its proprietary MPN technology. The company's slogan "Addressing 'undruggable' oncology targets by delivering whole antibodies inside the tumor and metastatic cells" emphasizes its unique approach to addressing challenging oncology targets. LiberaBio's nanotechnology actively targets tumor and metastatic cells, delivering small and large molecules to on-surface or intracellular targets. The company's innovative approach includes creating new treatments by delivering novel antibodies targeting intracellular oncoproteins. The company recently received a grant investment at 21 April 2023 from The EmprendeXXI Awards, highlighting investor confidence in LiberaBio's potential in the biopharma, life sciences, and pharmaceutical industries. With its targeted approach and recent investment, LiberaBio is well-positioned to make significant strides in the field of oncology treatment.

Taxonomy: Oncology, Nanomedicine, Drug delivery, Antibodies, Biosimilars, Active targeting, Intracellular, Oncoproteins, Cytotoxics

Services & Products

Development of intracellular biologics and small molecule therapies for cancer treatment

Target Customers

Biopharmaceutical companies oncology researchers potential investors

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 21 Apr 2023
Seed Round •••••• 3
Investor
•••• •••• 		19 Jul 2022
Seed Round •••••• 1
Investor
23 Dec 2021
Seed Round •••••• - 01 Jul 2021

LiberaBio Alternatives & Competitors

LiberaBio vs
Biond Biologics Ltd
Biond Biologics Ltd Israel

Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics for the tre...

Series C
43 employees
Biotechnology, Health Care
LiberaBio vs
Vesigen Therapeutics, Inc.
Vesigen Therapeutics, Inc. United States

Delivering intracellular therapeutics with ARMMed microvesicles

Grant
19 employees
Biotechnology, Health and Wellness
LiberaBio vs
Innate Biologics, LLC
Innate Biologics, LLC United States

A Pioneer In Targeting, Treating and Preventing Inflammation

3 employees

FAQ About LiberaBio

Addressing "undruggable"​ oncology targets by delivering whole antibodies inside the tumor and metastatic cells.
LiberaBio was founded in 2018.
LiberaBio is headquartered in Spain.
LiberaBio operates in the following industries: Biopharma, Life Sciences, Pharmaceutical.
LiberaBio has approximately 11 employees.
LiberaBio has completed 4 funding rounds, raising a total of $1.30M. The latest funding stage is Grant.
LiberaBio offers: Development of intracellular biologics and small molecule therapies for cancer treatment.
Top alternatives and competitors to LiberaBio include Biond Biologics Ltd, Vesigen Therapeutics, Inc., Innate Biologics, LLC , Larimar Therapeutics Inc., Sapreme Technologies BV. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
LiberaBio and Biond Biologics Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors LiberaBio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy